info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Kidney Stone Market Research Report Information by Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Forecast Till 2032


ID: MRFR/HC/1213-CR | 117 Pages | Author: Kinjoll Dey| February 2021

Kidney Stone Market Segmentation


Kidney Stone Type Outlook (USD Billion, 2019-2030)




  • Calcium Oxalate Stones




  • Uric Acid




  • Struvite Kidney Stones




  • Cystine Stones




  • Calcium Phosphate Stones




Kidney Stone Treatment Type Outlook (USD Billion, 2019-2030)




  • Medications




  • Extracorporeal Shock Wave Lithotripsy




  • Ureteroscopy




  • Percutaneous Nephrolithotomy




Kidney Stone Diagnosis Outlook (USD Billion, 2019-2030)




  • Specialty Ultrasound




  • Intravenous Pyelography




  • CT Scan




  • X-Ray




  • Others




Kidney Stone Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • North America Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • North America Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • US Outlook (USD Billion, 2019-2030)




    • US Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • US Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • US Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Canada Outlook (USD Billion, 2019-2030)




    • Canada Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Canada Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Canada Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Europe Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Europe Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Germany Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Germany Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • France Outlook (USD Billion, 2019-2030)




    • France Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • France Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • France Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • UK Outlook (USD Billion, 2019-2030)




    • UK Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • UK Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • UK Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Italy Outlook (USD Billion, 2019-2030)




    • Italy Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Italy Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Italy Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Spain Outlook (USD Billion, 2019-2030)




    • Spain Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Spain Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Spain Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Rest Of Europe Outlook (USD Billion, 2019-2030)




    • Rest Of Europe Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Rest of Europe Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Rest of Europe Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Asia-Pacific Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Asia-Pacific Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • China Outlook (USD Billion, 2019-2030)




    • China Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • China Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • China Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Japan Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Japan Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • India Outlook (USD Billion, 2019-2030)




    • India Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • India Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • India Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Australia Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Australia Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • South Korea Outlook (USD Billion, 2019-2030)




    • South Korea Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • South Korea Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • South Korea Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Rest of Asia-Pacific Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Rest of Asia-Pacific Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others




      • ย 








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Rest of the World Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Rest of the World Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Middle East Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Middle East Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Africa Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Africa Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Kidney Stone by Type




      • Calcium Oxalate Stones




      • Uric Acid




      • Struvite Kidney Stones




      • Cystine Stones




      • Calcium Phosphate Stones






    • Latin America Kidney Stone by Treatment Type




      • Medications




      • Extracorporeal Shock Wave Lithotripsy




      • Ureteroscopy




      • Percutaneous Nephrolithotomy






    • Latin America Kidney Stone by Diagnosis




      • Ultrasound




      • Intravenous Pyelography




      • CT Scan




      • X-Ray




      • Others







Research Methodology on Kidney Stones Market


The research for this report is conducted to understand the market dynamics and gain insights into the overall market size of the Kidney Stones market, its forecasts from 2023 to 2030 and industry trends in the respective regions. The report on the Kidney Stones market is created with the help of a detailed market research methodology. The whole report is a pure result of a thorough market research process.


1.ย  Secondary Research


The secondary research method is used to gain insights into the Kidney Stones market. Comprehensive secondary research is conducted by gathering data from various secondary sources such as company websites, press releases, statistical databases, publications, annual reports, SEC filings, World Bank databases, and other such sources.


For a deep understanding of the Kidney Stones market, secondary research was extensively used by the analysts and was mainly directed to gain an understanding of the industry and its various components. Besides, the insights into historical background, current market statistics, current policies, government initiatives, and prevailing trends in the Kidney Stones industry were also obtained.


2. Primary Research


Apart from the secondary research, a thorough market study involved the primary research conducted by the analysts. The estimated data collected from the secondary research is further validated by conducting extensive primary interviews with the industry experts such as CEOs, doctors, healthcare professionals and other stakeholders. Primary interviews were used to gain in-depth insights into the competitive landscape and market trends. The data points obtained through the primary research were further scrutinized for accuracy and validation using various industry-specific databases.


3. Market Size Estimation


The market size estimation of the Kidney Stones market was conducted based on the top-down and bottom-up approaches. The top-down approach was used to estimate the total Kidney Stones market size by dividing the total market size of diagnostics into different segments, namely, contributor countries & device types. Production, import & export data from respective countries are then used to perform validation for calculating the final market size. The bottom-up approach is used to estimate the individual Kidney Stones market size for the market segmentation. The analyst gathered data from the pre-existing production lines, manufacturers and distributors.


4. Data Triangulation


The market shares of the Kidney Stones market were estimated by analyzing data from both primary and secondary sources. The data is triangulated by studying different trends from both primary and secondary sources. The major focus was on five factors, namely production analysis, end-user analysis, regional analysis, pricing analysis and market dynamics.


5. Market Breakdown and Data Validation


The data gathered during the market research process is used to deduce the current market size and the future market size of the Kidney Stones market. This was done by carefully studying the existing market dynamics. The data is also cross-checked and validated by various sources to identify inconsistencies and outliers.


6. Report Analysis


The report on the Kidney Stones market has been organized by analyzing the collected data through a two-step analysis process. The first step involved the analysis of production, supply-demand, sales, and each segment and sub-segment. The second step included the analysis of the key industry players and their product portfolio, major regional presence, and partnership allotment with their competitors.


The report is finally concluded by summarizing the key findings from all the analytical studies and incorporating business strategies by key players and industry trends that could affect the demand for Kidney Stones products.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Introduction

2.1 Definition 13

2.2 Scope of Study 13

2.3 Research Objective 13

2.4 Assumptions & Limitations 13

2.4.1 Assumptions 13

2.4.2 Limitations 13

2.5 Market Structure 14

3 Research Methodology

3.1 Primary Research 16

3.2 Secondary Research 16

4 Market Dynamics

4.1 Introduction 17

4.2 Drivers 17

4.2.1 Minimally Invasive Procedures for Treatment of Kidney Stones has Boosted Market Growth 17

4.2.2 Increasing Incidence of Urolithiasis in the Adult Population 18

4.2.3 Poor Nutrition Driving Rise in Kidney Stones Market 18

4.3 Restraints 18

4.3.1 Adverse Effects of Extracorporeal Shock Wave Lithotripsy 18

4.4 Opportunity 19

4.4.1 Advance Medications for Kidney Treatment 19

5 Market Factor Analysis

5.1 Porters Five Forces Model 20

5.1.1 Bargaining Power of Suppliers 21

5.1.2 Bargaining Power of Buyers 21

5.1.3 Threat of New Entrants 21

5.1.4 Threat of Substitutes 21

5.1.5 Intensity of Rivalry 22

5.2 Value Chain Analysis 22

5.2.1 Research & Product Developments 22

5.2.2 Manufacturing 23

5.2.3 Distribution 23

5.2.4 Marketing & Sales 23

5.2.5 Post-Sales Services 23

6 Kidney Stones Market, by Types

6.1 Introduction 24

6.2 Calcium Oxalate Stones 25

6.3 Uric Acid 26

6.4 Struvite Kidney Stones 28

6.5 Cystine Stones 28

6.6 Calcium Phosphate Stones 28

7 Kidney Stones Market, by Treatment Types

7.1 Introduction 30

7.2 Medications 31

7.3 Extracorporeal Shock Wave Lithotripsy (ESWL) 32

7.4 Ureteroscopy (URS) 32

7.5 Percutaneous Nephrolithotomy (PCNL) 33

8 Kidney Stone Market, by Diagnosis

8.1 Introduction 35

8.2 Ultrasound 37

8.3 Intravenous Pyelography (IVP) or Intravenous Urogram 38

8.4 CT Scan 39

8.5 X-ray 40

8.6 Others 40

9 Global Kidney Stone Market, by Region

9.1 Introduction 41

9.2 North America 43

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.2.1 US 45

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.2.2 Canada 48

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3 Europe 50

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3.1 Germany 52

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3.2 France 54

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3.3 UK 56

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3.4 Italy 57

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3.5 Spain 59

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.3.6 Rest of Europe 60

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4 Asia-Pacific 63

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4.1 China 65

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4.2 Japan 67

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4.3 India 69

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4.4 South Korea 70

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4.5 Australia 72

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.4.6 Rest of Asia-Pacific 74

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.5 Middle East & Africa 77

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.5.1 UAE 80

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.5.2 Saudi Arabia 82

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.5.3 Egypt 84

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

9.5.4 Rest of Middle East & Africa 86

Kidney Stones Market, by Types

Kidney Stones Market, by Treatment Types

Kidney Stone Market, by Diagnosis

10 Competitive Landscape

11 Company Profiles

11.1 Boston Scientific Corporation 90

11.1.1 Company Overview 90

11.1.2 Product/Business Segment Overview 90

11.1.3 Financial Overview 91

11.1.4 Key Developments 91

11.1.5 MRFR Analysis 92

11.2 Convergent Laser Technologies 93

11.2.1 Company Overview 93

11.2.2 Product/Business Segment Overview 93

11.2.3 Financial Overview 93

11.2.4 Key Developments 93

11.2.5 MRFR Analysis 93

11.3 DirexGroup 94

11.3.1 Company Overview 94

11.3.2 Product/Business Segment Overview 94

11.3.3 Financial Overview 94

11.3.4 Key Developments 94

11.3.5 MRFR Analysis 94

11.4 Siemens Healthcare GmbH 95

11.4.1 Company Overview 95

11.4.2 Product/Business Segment Overview 95

11.4.3 Financial Overview 95

11.4.4 Key Developments 96

11.4.5 MRFR Analysis 97

11.5 C.R. Bard Inc. 98

11.5.1 Overview 98

11.5.2 Product Overview 98

11.5.3 Financials 98

11.5.4 Key Developmentss 99

11.5.5 MRFR Analysis 99

11.6 Cook Medical Inc. 100

11.6.1 Overview 100

11.6.2 Product Overview 100

11.6.3 Financials 100

11.6.4 Key Developmentss 101

11.6.5 MRFR Analysis 101

11.7 Dornier MedTech GmbH 102

11.7.1 Overview 102

11.7.2 Product Overview 102

11.7.3 Financials 102

11.7.4 Key Developmentss 102

11.7.5 MRFR Analysis 103

11.8 Richard Wolf Medical Instruments Corporation 104

11.8.1 Overview 104

11.8.2 Product Overview 104

11.8.3 Financials 104

11.8.4 MRFR Analysis 104

11.9 Olympus Corporation 105

11.9.1 Overview 105

11.9.2 Product Overview 105

11.9.3 Financials 106

11.9.4 Key Developmentss 106

11.9.5 MRFR Analysis 107

11.10 Stryker Corporation 108

11.10.1 Overview 108

11.10.2 Product overview 108

11.10.3 Financials 108

11.10.4 Key Developmentss 109

11.10.5 MRFR Analysis 109

12 List of Tables

TABLE 1 GLOBAL KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 25

TABLE 2 GLOBAL CALCIUM MARKET, BY REGION, 2023-2030 (USD MILLION) 26

TABLE 3 GLOBAL URIC ACID MARKET, BY REGION, 2023-2030 (USD MILLION) 27

TABLE 4 GLOBAL STRUVITE MARKET, BY REGION, 2023-2030 (USD MILLION) 28

TABLE 5 GLOBAL CYSTINE MARKET, BY REGION, 2023-2030 (USD MILLION) 29

TABLE 6 GLOBAL KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 31

TABLE 7 GLOBAL MEDICATIONS MARKET, BY REGION, 2023-2030 (USD MILLION) 31

TABLE 8 GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) MARKET, BY REGION, 2023-2030 (USD MILLION) 32

TABLE 9 GLOBAL URETEROSCOPY (URS) MARKET, BY REGION, 2023-2030 (USD MILLION) 33

TABLE 10 GLOBAL PERCUTANEOUS NEPHROLITHOTOMY (PCNL) MARKET, BY REGION, 2023-2030 (USD MILLION) 34

TABLE 11 GLOBAL KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 36

TABLE 12 GLOBAL ULTRASOUND MARKET, BY REGION, 2023-2030 (USD MILLION) 37

TABLE 13 GLOBAL INTRAVENOUS PYELOGRAPHY (IVP) OR INTRAVENOUS UROGRAM MARKET, BY REGION, 2023-2030 (USD MILLION) 38

TABLE 14 GLOBAL CT SCAN MARKET, BY REGION, 2023-2030 (USD MILLION) 39

TABLE 15 GLOBAL X-RAY MARKET, BY REGION, 2023-2030 (USD MILLION) 40

TABLE 16 GLOBAL KIDNEY STONE MARKET, BY REGION, 2023-2030 (USD MILLION) 42

TABLE 17 NORTH AMERICA KIDNEY STONE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 43

TABLE 18 NORTH AMERICA KIDNEY STONE MARKET, BY TYPES, 2023-2030 (USD MILLION) 44

TABLE 19 NORTH AMERICA KIDNEY STONE MARKET, BY TREATMENT TYPES, 2023-2030 (USD MILLION) 44

TABLE 20 NORTH AMERICA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 45

TABLE 21 US KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 45

TABLE 22 US KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 46

TABLE 23 US KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 47

TABLE 24 CANADA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 48

TABLE 25 CANADA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 48

TABLE 26 CANADA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 49

TABLE 27 EUROPE KIDNEY STONE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 50

TABLE 28 EUROPE KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 51

TABLE 29 EUROPE KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 51

TABLE 30 EUROPE KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 52

TABLE 31 GERMANY KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 52

TABLE 32 GERMANY KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 53

TABLE 33 GERMANY KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 53

TABLE 34 FRANCE KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 54

TABLE 35 FRANCE KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 54

TABLE 36 FRANCE KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 55

TABLE 37 UK KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 56

TABLE 38 UK KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 56

TABLE 39 UK KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 57

TABLE 40 ITALY KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 57

TABLE 41 ITALY KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 58

TABLE 42 ITALY KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 58

TABLE 43 SPAIN KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 59

TABLE 44 SPAIN KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 59

TABLE 45 SPAIN KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 60

TABLE 46 REST OF EUROPE KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 60

TABLE 47 REST OF EUROPE KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 61

TABLE 48 REST OF EUROPE KIDNEY STONE MARKET, BY DIAGNOSIS TYPE, 2023-2030 (USD MILLION) 62

TABLE 49 ASIA-PACIFIC KIDNEY STONE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 63

TABLE 50 ASIA-PACIFIC KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 64

TABLE 51 ASIA-PACIFIC KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 64

TABLE 52 ASIA-PACIFIC KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 65

TABLE 53 CHINA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 65

TABLE 54 CHINA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 66

TABLE 55 CHINA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 67

TABLE 56 JAPAN KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 67

TABLE 57 JAPAN KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 68

TABLE 58 JAPAN KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 68

TABLE 59 INDIA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 69

TABLE 60 INDIA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 69

TABLE 61 INDIA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 70

TABLE 62 SOUTH KOREA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 70

TABLE 63 SOUTH KOREA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 71

TABLE 64 SOUTH KOREA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 72

TABLE 65 AUSTRALIA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 72

TABLE 66 AUSTRALIA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 73

TABLE 67 AUSTRALIA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 73

TABLE 68 REST OF ASIA-PACIFIC KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 74

TABLE 69 REST OF ASIA-PACIFIC KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 75

TABLE 70 REST OF ASIA-PACIFIC KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 76

TABLE 71 MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 77

TABLE 72 MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY TYPES, 2023-2030 (USD MILLION) 78

TABLE 73 MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 79

TABLE 74 MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 80

TABLE 75 UAE KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 80

TABLE 76 UAE KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 81

TABLE 77 UAE KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 81

TABLE 78 SAUDI ARABIA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 82

TABLE 79 SAUDI ARABIA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 83

TABLE 80 SAUDI ARABIA KIDNEY STONE MARKET, BY DIAGNOSIS TYPE, 2023-2030 (USD MILLION) 84

TABLE 81 EGYPT KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 84

TABLE 82 EGYPT KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 85

TABLE 83 EGYPT KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 85

TABLE 84 REST OF MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY TYPE, 2023-2030 (USD MILLION) 86

TABLE 85 REST OF MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 87

TABLE 86 REST OF MIDDLE EAST & AFRICA KIDNEY STONE MARKET, BY DIAGNOSIS, 2023-2030 (USD MILLION) 88

TABLE 87 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS 91

TABLE 88 SIEMENS HEALTHCARE: KEY DEVELOPMENTS 96

TABLE 89 C.R. BRAD INC: KEY DEVELOPMENTS 99

TABLE 90 COOK MEDICAL: KEY DEVELOPMENTSS 101

TABLE 91 OLYMPUS: KEY DEVELOPMENTSS 106

13 List of Figures

FIGURE 1 RESEARCH PROCESS 15

FIGURE 2 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL KIDNEY STONE MARKET 20

FIGURE 3 VALUE CHAIN: MEDICAL EQUIPMENT 22

FIGURE 4 GLOBAL KIDNEY STONE MARKET SHARE, BY TYPE, 2023 (%) 24

FIGURE 5 GLOBAL KIDNEY STONE MARKET SHARE, BY TREATMENT TYPES, 2023 (%) 30

FIGURE 6 GLOBAL KIDNEY STONE MARKET SHARE, BY DIAGNOSIS, 2023 (%) 35

FIGURE 7 GLOBAL KIDNEY STONE MARKET SHARE, BY REGION, 2023 (%) 41

FIGURE 8 NORTH AMERICA KIDNEY STONE MARKET, BY COUNTRY, 2023 (%) 43

FIGURE 9 EUROPE KIDNEY STONE MARKET, BY COUNTRY, 2023 (%) 50

FIGURE 10 ASIA-PACIFIC KIDNEY STONE MARKET, BY COUNTRY, 2023 (%) 63

FIGURE 11 MARKET COMPETITIVE ANALYSIS BY KEY PLAYERS, 2023 (%) 89

FIGURE 12 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 91

FIGURE 13 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 91

FIGURE 14 SIEMENS HEALTHCARE: RECENT FINANCIAL 95

FIGURE 15 SIEMENS HEALTHCARE: RECENT FINANCIAL 96

FIGURE 16 SIEMENS HEALTHCARE: GEOGRAPHIC MIX 96

FIGURE 17 C.R. BARD INC: RECENT FINANCIALS 98

FIGURE 18 C.R. BRAD INC: SEGMENT REVENUE (%) 99

FIGURE 19 OLYMPUS: RECENT FINANCIALS 106

FIGURE 20 OLYMPUS: SEGMENT FININCIALS 2023 (%) 106

FIGURE 21 STRYKER: RECENT FINANCIALS 108

FIGURE 22 STRYKER: GEOGRAPHICAL REVENUE 109

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.